TechnologyBusinessScience

bioCircular Loop

Melina Gerdts

bioCircular Loop is the podcast about success stories, innovation and newest developments in the European circular Bioeconomy. It aims to educate, inform and inspire listeners with content about how circular bioeconomy presents the answer to humanity's greatest societal challenges, especially climate change and resource depletion. The podcast hosts the people that are driving this industrial bio-revolution, each episode deep-dives into a different organisation, industry and technology.

Play

Open in

20 episodes
Avg 30 min
English

Support the show

Goes straight to the publisher. podnod takes nothing.

Support this Podcast

Episodes 20

Newest Oldest Longest

All20 Unplayed20 In progress0 Played0

S3 · E22
August 24 · 1 hr 5 min
#22 You failed? Good! Why failing fast is essential for breakthrough innovation in biomanufacturing ft. SPRIND
Send us Fan Mail Melina Gerdts introduces the concept of disruptive innovation as a necessary force for systemic change in society. She discusses the insights from Natalie Kyriacu's speech on humanity's contradictions and hosts Patrick Rose, the Innovation Manager at SPRIND, a state-owned agency in Germany focused on fostering unconventional technologies. Patrick explains SPRIND's unique approach to funding and supporting innovative projects, emphasizing the importance of a fail-fast culture and the role of government in driving innovation. The episode concludes with a discussion on the scope of innovations supported by SPRIND and Patrick's vision for the future of innovation. Patrick discusses the innovative SPRIND Challenge in Circular Biomanufacturing, the unique support system for startups at SPRIND, and the cultural differences in accepting failure between Europe and the US. He emphasizes the importance of risk tolerance and the need for a shift in mindset to foster innovation. The discussion also highlights the global influence of SPRIND's model and its potential to inspire similar initiatives worldwide. SPRIND SPRIND Challenge: Circular Biomanufacturing Natalie Kyriacou is the author of Nature's Last Dance: Tales of Wonder in an Age of Extinction. Natalie Kyriacou full speech. This is her speech at Reclaiming Democracy Together, an event by Conversations at the Crossroads Support the show
S3 · E21
August 3 · 43 min
#21 Precision fermentation of fats and oils to avoid deforestation and increase national security ft. ÄIO
Send us Fan Mail bCL is back! In this episode of the bioCircular Loop podcast, Melina Gerdts interviews Nemailla Bonturi, co-founder of ÄIO, a startup based in Estonia that focuses on brewing fats and oils through precision fermentation technology. Nemailla shares her journey from being a scientist to an entrepreneur, the innovative processes behind ÄIO, and the challenges of navigating regulatory landscapes and securing funding. The conversation also touches on the importance of sustainability, circular economy practices, and the future of food technology. Check out ÄIO at https://aio.bio/. Support the show
S2 · E11
March 24 · 22 min
A Pitch Perfect Miniseries | #11 Can Europe keep up with China and US in scaling bio? ft. Bio Base Europe Pilot Plant
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this final episode of the miniseries features Hendrik Waegeman, Head of Business Operations at Biobase Europe Pilot Plant, reflecting on what it really takes to scale bio-based innovation in Europe. After two days of panels, pitches and workshops, the big question remains simple: how do we scale successfully? Hendrik breaks it down. Whether you are a startup or a corporate, the fundamentals are the same. Product market fit. Price competitiveness. Scalability. Fast time to market. The difference is often how you deal with those factors. Startups are pushed to move fast. Corporates move step by step. And in bio-based scale-up, step by step matters. At lab scale everything looks perfect. At industrial scale, pressure, shear, mixing, oxygen gradients and equipment realities change the game. The devil really is in the details. We also talk about: Why unrealistic cost assumptions can kill a scale-up The importance of early techno-economic assessments Surrounding yourself with experienced advisors Partnerships as a necessity, not a luxury Dedication as the defining founder trait Then we zoom out. Europe has historically been strong in pilot and demo infrastructure. But the US, China, India and others are investing heavily and moving fast. Europe analyzes well, but acts slowly. The race is getting more competitive. One takeaway that sticks: think big, act small. Keep moving, even when funding slows down or the path gets messy. This closes our 11-episode Pitch Perfect miniseries on scaling bio-based innovation. If you made it through all of them, you now have a pretty realistic picture of what scaling actually looks like. Not the hype version. The real one. If you’re building, investing, or scaling in the bioeconomy and want to share your own journey, lessons, or setbacks, send us a message on LinkedIn. The scale-up story is far from over. This episode is part of a Miniseries powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E10
March 17 · 17 min
A Pitch Perfect Miniseries | #10 When the corporate opts out: scaling a bio-based PET alternative anyway ft. Tasseikan
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Marc Lankveld, Founder of Tasseikan, on building a biotech route to replace PET with a bio-based alternative. Tasseikan develops a fermentation process that converts sugar into FDCA, a building block for PEF, a bioplastic designed to substitute PET in packaging. Think bottles, food packaging, and applications where strength and gas barrier properties really matter. Unlike PLA, PEF is not biodegradable. It is meant to be recycled. The goal is not compostable plastic, but a drop-in, high-performance alternative to fossil-based PET. Marc shares the full journey. It started 15 years ago at Delft University, was scaled once inside Corbion, paused when strategic priorities shifted, and then rebuilt from scratch. Today the company is back in pilot phase and preparing for the next step: a demo facility. A few key themes from the conversation: Scaling is not just about the process. You need the application and value chain ready as well. Strategic partnerships matter. Tassekan works contractually with Technip Energies, keeping agility while leveraging large-scale engineering expertise. Entrepreneurs need optimism, but also realism. Plan for success. And plan for what could go wrong. One line that sticks: think big, act small. Scaling bio-based plastics is a long game. It requires patience, partnerships, and the ability to deal with whatever situation comes next. If you’re working on bio-based materials or industrial biotech, this episode is a grounded look at what rebuilding and scaling really takes. This episode is part of a Miniseries powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E9
March 10 · 11 min
A Pitch Perfect Miniseries | #9 Biotech and baking: the secret ingredient to successful scaling ft. Puratos
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Bram Pareyt, Group Upstream R&D Director at Puratos, on what biomanufacturing actually looks like inside a global food ingredients company. Puratos is a B2B producer of ingredients for bakery, patisserie and chocolate. But behind the scenes, biotech plays a much bigger role than you might think. For Bram and his team, biomanufacturing means enzymes, functional fermentation and using nature as inspiration. One example is a thermostable protease inspired by Yellowstone, developed and scaled in-house to improve texture, extend shelf life and contribute to cleaner labels. It started as a technical project. It became a health and functionality play. We talk about what it takes to scale biotech inside a corporate: Focus and dedicated teams Aligning biotech expertise with application expertise Understanding how and why a technology works, not just that it works Continuous screening for new startup partners via Sparkalis And then we get into the real tension: economics. A solution that costs ten times more than the benchmark will struggle, no matter how sustainable it is. Consumers may care about clean label and health, but there is still an economic reality in food. Regulatory complexity in Europe adds another layer. Bram also shares practical advice for founders: bring a real solution to a real problem. Not just a dream. Be clear about what you are good at and where you need help. Build trust early. If you want to understand how biotech scales inside established food companies and what corporates actually look for in partnerships, this episode is a very honest look behind the curtain. This episode is powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E8
March 3 · 11 min
A Pitch Perfect Miniseries | #8 Rethinking crop protection: Can Llama antibodies replace chemical pesticides? ft. Biotalys
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Bart Walcarius, Head of Technology Integration at Biotalys, on what it really takes to scale protein-based crop protection Biotalys is developing biodegradable, protein-based biocontrols as an alternative to conventional chemical pesticides. The twist? Their technology is built on unique single-chain antibodies derived from camels and llamas, engineered into highly specific proteins that target crop pests and diseases with precision. We talk about: Why cost of goods is everything in agriculture Competing with ultra-cheap chemical pesticides Building high-performing production strains via precision fermentation Scaling from lab to pilot with Biobase Europe The importance of early manufacturing partnerships Why regulatory approval can make or break the timeline A major milestone: the US EPA has issued a proposed registration decision to approve their first biofungicide, EVOCA, a huge step toward entering the US market, potentially by 2028. But as Bart makes clear, scaling bio-based innovation in agriculture isn’t fast. It’s months and years of strain development, process optimization, regulatory work, and building trust with manufacturing partners. The key lesson? Start partnerships early. Build the right multidisciplinary team. And be patient, because real scale takes time. If you’re working at the intersection of biotech and agriculture, this will give you valuable insights on what it means to move from platform to product to field. This episode is powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E7
February 24 · 17 min
A Pitch Perfect Miniseries | #7 When there is no appetite for risk, who is funding FoodTech? ft. EIT Food
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Yvette Go, Investor at EIT Food, on what it really takes to finance and scale bio-based and food innovation in Europe. EIT Food, an initiative backed by the European Commission, supports agrifood innovation across the entire journey, from idea (TRL 1) to seed funding and beyond. Yvette sits right at the investment stage, bridging the gap between accelerator tickets and Series A capital. We dive into: What investors actually look for in bio-based startups Why market validation matters even at early stage The importance of supply chain positioning from day one Founder stamina and surrounding yourself with the right people What “scalability” really means (and what it doesn’t) We also unpack the food tech funding rollercoaster: After the 2021 peak, global food tech investment dropped by 70% (50% in Europe). The hype reset the market and pushed out generalists. What remains is a more specialized, hopefully wiser investor landscape. From agritech timelines to lab-grown food regulation, this conversation tackles the big question: how do we feed 10 billion people with finite resources? One thing is clear: this isn’t a short-term trend. It’s a long-term systems shift. If you’re building in food, ag, or bio-based innovation, this episode gives you the investor’s lens on what survives the reset. This episode is powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E6
February 17 · 17 min
A Pitch Perfect Miniseries | #6 From barrel to butanol: making green chemicals with whiskey waste ft. Celtic Renewables
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Martin Tangney, Founder & President of Celtic Renewables, one of Europe’s most established bio-based scale-up stories. Celtic Renewables takes biological residues from the Scottish whisky industry and turns them into high-value, low-carbon chemicals like acetone and butanol, the essential building blocks used in pharmaceuticals, cosmetics, food production, and everyday products. Less than 10% of what leaves a distillery becomes whisky. The rest? Untapped carbon. Celtic’s mission is simple: defossilize the chemical industry by squeezing more value out of what already exists above ground. In this episode, Martin shares: How a university research project became a commercial biorefinery Why the biggest leap in scaling is from lab to pilot The role of Biobase Europe in scaling 1,000x Why surrounding yourself with complementary skills is everything The hard truths about funding, risk, and “everyone wants to be first to be second” Why founders need resilience, but also balance One of the strongest takeaways: Don’t build a pier. Build a bridge. Get to the promised land, even if it’s not perfect. This is a candid conversation about scaling industrial biotech, reframing “waste” as resource, and why change is the real driver of the bioeconomy. This episode is powered by Bio Base Europe Pilot Plant. Support the show
S2 · E5
February 12 · 13 min
A Pitch Perfect Miniseries | #5 Blast furnaces & bacteria: scaling bio in heavy industry ft. ArcelorMittal
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Kristof Verbeeck, Business Development at ArcelorMittal Belgium, on what it actually means for heavy industry to bet on bio-manufacturing. ArcelorMittal Ghent is a 5-million-ton steel plant and the largest industrial CO₂ emitter in Belgium. Eight years ago, they decided to do something radical: build Europe’s first large-scale gas fermentation plant inside a steel mill, turning waste carbon monoxide and hydrogen into ethanol. Meet Steelanol. On paper, it made perfect sense: Higher-value product instead of flaring gases Avoided CO₂ emissions under the EU ETS system A potential cornerstone in the company’s decarbonization roadmap In reality? Scaling first-of-a-kind industrial biotech inside heavy industry is complex, technically and politically. We talk about: Why the EU ETS was central to the business case How changing regulation reshaped market access The challenge of certification under the Renewable Energy Directive What it takes to commission 550m³ fermenters at industrial scale Why innovation speed and regulatory speed are often misaligned The plant is built. It runs. Ethanol has been produced. But technical scale-up and regulatory frameworks still need to align for the model to fully deliver. Kristof shares candid insights into corporate risk-taking, regulatory uncertainty, and what startups should know before approaching heavy industry: validate your technology, understand corporate roadmaps, and don’t oversell. This episode is a real-world look at what happens when decarbonization moves from strategy slides into steel and concrete. This miniseries is powered by Bio Base Europe Pilot Plant and Pitch Perfect Bioeconomy. Support the show
S2 · E4
February 12 · 10 min
A Pitch Perfect Miniseries | #4 Paving the way to scale: the fungal future of roads ft. Visibuilt
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Line Kloster Pedersen, Founder & CEO of Visibuilt, and one of the boldest ideas we’ve seen on the bio-based stage this year. Visibuilt is developing the world’s first fungal binders for road construction, replacing fossil-based bitumen and highly polluting cement with mycelium, nature’s own underground binding network. Yes, you read that right. They’ve already built the world’s first mycelium bicycle parking lot in Denmark. We talk about: Why asphalt and concrete are massive climate problems How mycelium can bind rocks at low temperatures Cutting fossil dependency and energy use in construction Using local agricultural and forestry side streams What it really takes to scale biotech into heavy industry Line shares how a run around the lakes of Copenhagen sparked the idea — and how Visibuilt has since raised €4.7M, built a team of 18, and is now raising a €4.5M seed round to move from manual production to modular scale. This is bioeconomy in action: science leaving the lab and entering infrastructure. If more than 60% of the roads in 2050 haven’t been built yet, the question is simple: Why should they be fossil-based? This episode is powered by Bio Base Europe Pilot Plant. Support the show
S2 · E1
February 11 · 17 min
A Pitch Perfect Miniseries | #1 Lab to fab to geopolitics: Europe’s Bioeconomy at a crossroads ft. CBE-JU
Send us Fan Mail Recorded live at Pitch Perfect Bioeconomy in Brussels, this episode features Nicolo Giacomuzzi-Moore, Executive Director of CBE JU, on Europe’s competitiveness in scaling bio-based innovation from lab to market Ten years ago, the bioeconomy was niche. Today, it’s backed by EU strategies, public-private partnerships, and large-scale demonstration funding. Europe has successfully helped companies overcome the first valley of death, moving from research to first industrial plants. But the real challenge remains: commercial scale. We unpack how Europe compares to the US and China, why access to capital is the missing link, and how regulatory clarity, standards, public procurement, and the European Investment Bank could unlock the next phase of growth. There’s no silver bullet. The key is alignment, between policy, finance, and market demand. If you’re building, investing, or shaping policy in the bio-based economy, this conversation is for you. This episode is powered by Bio Base Europe Pilot Plant. Support the show
S2 · E2
February 11 · 12 min
A Pitch Perfect Miniseries | #2 Breaking Down the EU’s Bioeconomy Strategy: From Policy to Scale ft. EU Commission
Send us Fan Mail Recorded live at Pitch Perfect Bioeconomy in Brussels (24–25 November 2025), this episode features Agata Kotkowska from the European Commission on the new EU Bioeconomy Strategy and what it really means for scaling bio-based innovation in Europe. The message is clear: Europe has the science, the infrastructure, and the know-how. What’s missing? Speed. With China, the US and India accelerating investments in bio-manufacturing, competitiveness is no longer abstract, it’s urgent. The new strategy focuses on: Scaling from lab to deployment Building real lead markets (construction, biochemicals, textiles, biorefineries) Ensuring sustainable biomass use Strengthening Europe’s global position But this isn’t just about policy papers. It’s about simplifying regulation, aligning investors and innovators, and treating the bioeconomy as a serious growth engine, not a side topic. If Europe wants to lead, business as usual won’t cut it. This episode is powered by Bio Base Europe Pilot Plant. Support the show
S2 · E3
February 11 · 15 min
A Pitch Perfect Miniseries | #3 Bioreactors don't do beta versions and why tech VCs are out of their league with bio ft. Capricorn Partners
Send us Fan Mail Recorded live at the Pitch Perfect Bioeconomy event in Brussels, this episode features Rob van der Meij, Partner at Capricorn Partners, on what it really takes to scale bio-based innovation. The key message? Scaling bio is not like scaling software. As an investor who has helped grow multiple tech-driven companies, Rob breaks down why process development is the most underestimated factor in bio-based scale-up. In digital, you can iterate fast. In bio-based manufacturing, scale-up is sequential, capital-intensive, and often more art than science. We dive into: Why process data matters more than pitch decks Why rushing scale can destroy value Why MVP thinking doesn’t work in industrial biotech When equity, grants, debt, and government-backed loans make sense Why the right investor mix is critical in early phases In bio-based industries, 90% of the cost is defined in the first 10% of a capital project. Speed matters, but pushing at the wrong moment can cost years. For founders and investors navigating long R&D cycles, heavy CapEx, and patient capital, this is a grounded conversation about reality versus hype. If you’re building in the bioeconomy, this episode is a must-listen. This episode is powered by Bio Base Europe Pilot Plant. Support the show
S1 · E20
Nov 17, 2025 · 50 min
#20 No cows were harmed in the making of this episode ft. Qorium
Send us Fan Mail In this episode of the BioCircular Loop podcast, host Melina Gerdts discusses the advancements in the European circular bioeconomy, focusing on cellular agriculture and lab-grown leather. She interviews Michael Newton, CEO of Qorium, a Dutch startup pioneering lab-grown leather production. They explore the differences between European and American entrepreneurship ecosystems, the innovative processes behind lab-grown leather, and the sustainability and ethical implications of this technology. In this conversation, Michael Newton discusses the challenges and innovations within the leather industry, particularly focusing on sustainability and efficiency. He shares insights on scaling operations at Qorium, the cultural differences between the US and Europe in startup ecosystems, and offers advice for European founders. The discussion also highlights the significant environmental impact of Qorium's leather alternatives compared to traditional methods. Useful links Qorium Dutch Startup Qorium Bags $25M to bring Lab-Grown Leather to Market Entrepreneurship ecosystem theory Pitch Perfect Bioeconomy in Brussels Support the show
S1 · E19
Nov 10, 2025 · 56 min
#19 Biorevolution for democratic resilience ft. IFIB2025 & Mario Bonaccorso
Send us Fan Mail In this episode of the bioCircular Loop podcast, host Melina Gerdts recaps the 2025 edition of the International Forum for Industrial Biotechnology (IFIB) with Mario Bonacorso, the organizer and Director of the Italian SPRING cluster. They explore the topics discussed, highlighting the importance of circular bioeconomy in addressing global challenges such as climate change, waste management, and geopolitical dependence. The conversation emphasizes the need for collaboration, innovation, and effective communication to promote the bioeconomy as a viable solution for a sustainable future. This conversation delves into the pressing need for action in the bioeconomy sector, highlighting the importance of coherent regulatory frameworks, investment opportunities, and the role of clusters in fostering innovation. The speakers discuss the competitive landscape of Europe in the global bioeconomy, the challenges posed by overregulation, and the emerging trends that are shaping the future of sustainable practices across various industries. Personal insights into the evolution of the bioeconomy and the cultural shifts necessary for its growth are also shared. Useful links IFIB 2026 il bioeconomista - keep up to date with bioeconomy news SPRING - Italian cluster for circular bioeconomy European Biosolutions Coalition EU Bioeconomy Strategy 2025 Support the show
S1 · E18
Sep 29, 2025 · 40 min
#18 Chewy cheesy casein made with precision fermentation and the key to scaling this innovation ft. Standing Ovation
Send us Fan Mail In this episode of the bioCircular Loop podcast, Melina Gerdts discusses the challenges of sustainable protein production with Yvain Chardonnens, CEO of Standing Ovation. They explore the environmental impact of traditional dairy farming and the innovative process of producing casein through precision fermentation. The conversation highlights the founding story of Standing Ovation, the importance of casein in dairy products, and the company's mission to revolutionize the dairy industry with animal-free alternatives. https://standing-ovation.co/ Support the show
S1 · E17
Aug 18, 2025 · 46 min
#17 Making soil sexy again: food security, biodiversity & climate change depend on it ft. BetterSoil
Send us Fan Mail In this episode of the bioCircular Loop podcast, host Melina Gerdts discusses the critical role of soil in climate change mitigation, biodiversity preservation, and global food security with Azadeh Farajpur, Founder of BetterSoil. They explore the importance of soil health, the alarming rate of soil loss, and the impact of unsustainable agricultural practices. Azadeh shares her personal connection to soil and provides insights into what constitutes healthy soil, the dangers of monoculture, and the implications for food security as the global population grows. The conversation highlights the urgent need for regenerative practices to ensure soil health and sustainability for future generations. In this conversation, Azadeh discusses the critical role of soil in combating climate change and supporting biodiversity. The discussion also covers the innovative approaches her company, Better Soil, is taking to enhance soil management practices through technology and awareness-raising efforts. Support the show
S1 · E16
Jul 7, 2025 · 46 min
#16 A pineapple powered revolution: rethinking leather and empowering farmers in the Philippines while doing so ft. Ananas Anam
Send us Fan Mail In this episode of the Biocircular Loop podcast, Melina Gerdts interviews Dr. Carmen Hijosa, founder of Ananas Anam, about the innovative leather-substitute Pinatex, made from pineapple waste. They discuss the environmental impact of traditional leather production, the journey of creating a sustainable alternative, and the positive social impact on local communities in the Philippines. The conversation also covers market acceptance, challenges faced in the industry, and the vision for a sustainable future that heals the relationship between people and the planet. Support the show
S1 · E15
Jun 16, 2025 · 52 min
#15 How to cross the biotech Valley of Death and manage the bumpy road to scaling bio-based innovations ft. Bio-Base Europe Pilot Plant
Send us Fan Mail In this episode of the bioCircular Loop podcast, Melina Gerdts discusses the challenges biotech startups face in scaling their innovations from lab to industrial scale with Hendrik Waegeman, Head of Operations at the Bio-Base Europe Pilot Plant. They explore the high costs associated with scaling, the importance of collaboration and expertise, and the regulatory hurdles that can delay market entry. The conversation also highlights emerging trends in biobased applications, including alternative proteins, biopesticides, and food colorants. In this conversation, Hendrik Waegeman discusses the evolution of the bioeconomy, focusing on the transition to natural colorants, the complexities of biofuels, and the scaling of bio-based infrastructure in Europe. He highlights the international nature of their customer base, investment trends, and the regulatory challenges faced in the sector. Despite these challenges, he expresses optimism for the future of bio-based innovation, emphasizing the impact of BBEPP on sustainability and innovation in the bioeconomy. Useful Links https://www.bbeu.org https://www.sciencedirect.com/journal/efb-bioeconomy-journal https://www.sciencedirect.com/science/article/pii/S2667041022000118#:~:text=The large gap for academic,et al.%2C 2018). https://biopilots4u.eu https://www.sciencedirect.com/science/article/pii/S2667041022000118 https://theproteinnclub.eu Support the show
S1 · E14
May 19, 2025 · 43 min
#14 Building European resilience with bio-based innovation ft. Bio-based Industries Consortium (BIC)
Send us Fan Mail This episode of the bioCircular Loop podcast provides an in-depth exploration of the circular bioeconomy in Europe, featuring insights from Marco Rupp, Deputy Executive Director of the Bio-Based Industry Consortium (BIC). The discussion covers the evolution of the bioeconomy over the past decade, the role of innovation and funding, and the strategic importance of bio-based industries in addressing sustainability and climate change. Key themes include the challenges of biomass availability, the need for market creation, and the future outlook for bio-based industries in Europe amidst global geopolitical changes and growing demand for critical raw materials. Useful links: EU Bioeconomy strategy: https://research-and-innovation.ec.europa.eu/research-area/environment/bioeconomy/bioeconomy-strategy_en B.I.C. https://biconsortium.eu/ Bio-based Industries Consortium Annual Report 2024: https://biconsortium.eu/publication/bic-annual-report-2024 Circular Bio-based Europe Joined Undertaking: https://www.cbe.europa.eu/ Is there enough biomass to defossilize the chemicals and derived materials sector by 2050? https://biconsortium.eu/publication/there-enough-biomass-defossilise-chemicals-and-derived-materials-sector-2050 Support the show

Showing 1–20 of 20 episodes